Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Cancer (BTC)”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07437287
What this trial is testing

Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer (BTC)
UNICANCER 160
Testing effectiveness (Phase 2)WithdrawnNCT05041972
What this trial is testing

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Who this might be right for
HER2 Mutation-Related TumorsHER2 Amplified Solid Tumors
Ambrx, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT06467357
What this trial is testing

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
AstraZeneca 620
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Not applicableLooking for participantsNCT07466238
What this trial is testing

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Peking University 40
Post-approval studies (Phase 4)UnknownNCT02943031
What this trial is testing

The Effect of Individualized Precision Therapy Programs in Patients With BTC

Who this might be right for
Biliary Tract Neoplasms
RenJi Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06413745
What this trial is testing

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer

Who this might be right for
HER2 Expression / Amplification in Patients With Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd. 65
Testing effectiveness (Phase 2)WithdrawnNCT03768531
What this trial is testing

Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer

Who this might be right for
Resectable Biliary Tract Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)UnknownNCT06074029
What this trial is testing

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Who this might be right for
Biliary Tract CancerImmune Checkpoint InhibitorPredictive Cancer Model
Peking Union Medical College Hospital 50
Early research (Phase 1)Ended earlyNCT01949870
What this trial is testing

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Who this might be right for
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
AstraZeneca 6
Early research (Phase 1)Looking for participantsNCT06564623
What this trial is testing

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Looking for participantsNCT05849480
What this trial is testing

CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary CancerBile Duct CancerCancer of the Bile Duct
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Testing effectiveness (Phase 2)WithdrawnNCT03110510
What this trial is testing

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT06622057
What this trial is testing

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
InnoPharmax Inc. 195
Not applicableLooking for participantsNCT06648057
What this trial is testing

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
CHA University 100
Testing effectiveness (Phase 2)UnknownNCT03110484
What this trial is testing

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 44
Not applicableActive Not RecruitingNCT05036486
What this trial is testing

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
National Health Research Institutes, Taiwan 480
Testing effectiveness (Phase 2)Study completedNCT02425137
What this trial is testing

S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer(BTC)
TTY Biopharm 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490107
What this trial is testing

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

Who this might be right for
Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Load More Results